Switch View
© BusinessWire
27.08.2025
ISIN: US8292141053
Simulations Plus Inc
SLP
LISTED
NASDAQ
Simulations Plus to Participate in Upcoming Investor Conferences
News Preview
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced that Shawn O’Connor, Chief Executive Officer, will be participating in the following investor events...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: DE000BAY0017
Bayer AG
BAYN
LISTED
XETR
Gadoquatrane New Drug Application Accepted for Review by U.S. FDA
News Preview
Bayer today announced that a New Drug Application (NDA) for its investigational contrast agent gadoquatrane has been accepted for review by the U.S. Food and Drug Administration (FDA). The NDA for gadoquatrane has been filed for contrast-enhanced magnetic resonance imaging of the central nervous system (CNS) and other body regions in adults and pe...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US04280A1007
Arrowhead Pharmaceuticals Inc
ARWR
LISTED
NASDAQ
Arrowhead Pharmaceuticals to Participate in Upcoming September 2025 Conferences
News Preview
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:
European Society of Cardiology (ESC) Congress 2025 – August 29 - September 1, 2025
Title: A Randomized, Placebo-controlled Phase 3 Study of Plozasiran in Patients With FCS: Interim Analysis of Open Label Extensio...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© ACCESSWIRE
27.08.2025
ISIN: US60770K1079
Moderna, Inc
MRNA
LISTED
NASDAQ
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
News Preview
CAMBRIDGE, MA / ACCESS Newswire / August 27, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Applications (sBLA) for the 2025-2026 formulas for Spikevax® and mNEXSPIKE®, targeting the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19.Th...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© PR Newswire
27.08.2025
ISIN: CH0499880968
ADC Therapeutics SA
ADCT
LISTED
NYSE
ADC Therapeutics to Present at the Cantor Global Healthcare Conference 2025
News Preview
LAUSANNE, Switzerland, Aug. 27, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Wednesday, September...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US5526411021
MAIA Biotechnology Inc
MAIA
LISTED
XASE
MAIA Biotechnology Announces Publication of Interim Clinical Data on Telomere Targeting Anticancer Agent in Peer-Reviewed Journal Cells
News Preview
CHICAGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that a manuscript detailing developments in its Phase 2 THIO-101 clinical trial was accepted and published in the i...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: US98956P1021
Zimmer Biomet Holdings Inc
ZBH
LISTED
NYSE
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025
News Preview
WARSAW, Ind., Aug. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2025. The cash dividend of $0.24 per share is payable on or about October 31, 2...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US28106W1036
Editas Medicine Inc
EDIT
LISTED
NASDAQ
Editas Medicine to Participate in Upcoming Investor Conferences
News Preview
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that management will participate in the following upcoming investor conferences in September:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US2075231017
Connect Biopharma Holdings Ltd
CNTB
LISTED
NASDAQ
Connect Biopharma to Present at Two Upcoming Investor Conferences in September
News Preview
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company focused on transforming care for the treatment of inflammatory diseases, today announced that Company management will participate in the following upcoming conferenc...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US7611521078
Resmed Inc
RMD
LISTED
NYSE
Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
News Preview
Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, preventative strategies, and personalized care Published in The Lancet Respiratory Medicine, research reveals sharp rise in OSA, especially among women, highlighting the need for earlier diagnosis, p...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2025
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will participate in a fireside chat at the Cantor Global Healthcare Conference 2025 on Wednesday, September 3, 2025, at 10:55 a.m. ET.
A live webcast of the presentation will be available on the Company’s website at www.kalvista.com. An audio archive will be availabl...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US03237H1014
Amylyx Pharmaceuticals Inc
AMLX
LISTED
NASDAQ
Amylyx Pharmaceuticals to Discontinue ORION Program of AMX0035 for Progressive Supranuclear Palsy (PSP)
News Preview
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced the decision to discontinue the ORION program of AMX0035 (sodium phenylbutyrate [PB] and taurursodiol [TURSO, also known as ursodoxicoltaurine]) in adults living with progressive supranuclear palsy (PSP).
AMX0035 did not show differences compared to placebo o...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
27.08.2025
ISIN: US58933Y1055
Merck & Co Inc
MRK
LISTED
NYSE
HERTHENA-Breast04 Phase 3 Trial of Patritumab Deruxtecan Initiated in Patients with Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer Previously Treated with Endocrine Therapy
News Preview
The first patient has been dosed in the HERTHENA-Breast04 phase 3 trial evaluating the efficacy and safety of investigational patritumab deruxtecan (HER3-DXd) versus investigator’s choice of treatment in patients with unresectable locally advanced or metastatic hormone receptor (HR) positive, HER2 negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast can...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US31573L1052
FibroBiologics Inc.
FBLG
LISTED
NASDAQ
FibroBiologics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
News Preview
HOUSTON, Aug. 27, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced that Founder and Chief...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US5288723027
Lexicon Pharmaceuticals Inc
LXRX
LISTED
NASDAQ
Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences
News Preview
THE WOODLANDS, Texas, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at Citi's Biopharma Back to School Conference on Wednesday, September 3 at 1:45 p.m. ET and at the H.C. Wainwright 27th Annual Global Investment Conference on Monday, Sept...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US0197701065
Allogene Therapeutics Inc
ALLO
LISTED
NASDAQ
Allogene Therapeutics Announces Participation in Upcoming Investor Conference
News Preview
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that it will participate in one upcoming investor conference in September....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US53635D2027
Liquidia Corp
LQDA
LISTED
NASDAQ
Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference
News Preview
MORRISVILLE, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that members of the company’s executive leadership team will be providing an update on the company's business during a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, beginning at 3:45 p.m. ET in Bo...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US15117F3029
Cellectar Biosciences, Inc.
CLRB
LISTED
NASDAQ
Cellectar Biosciences to Present Data in Oral Session and Panel Discussions at the American Association for Cancer Research Special Conference on Discovery and Innovation in Pediatric Cancer
News Preview
Presenting Data from CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) Patients Presenting Data from CLOVER-2 Phase 1 Clinical Study Evaluating Iopofosine I 131 in Relapsed/Refractory Pediatric High-Grade Glioma (r/r pHGG) Patients...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US56400P2011
MannKind Corporation
MNKD
LISTED
NASDAQ
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy
News Preview
MannKind Announces Expansion of United Therapeutics Collaboration for Second Inhaled Therapy...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US6294441000
NRx Pharmaceuticals, Inc.
NRXP
LISTED
NASDAQ
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 (preservative-free ketamine)
News Preview
WILMINGTON, Del., Aug. 27, 2025 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq:NRXP), a clinical-stage biopharmaceutical company, today announced its expanded access policy for NRX-100 (preservative-free ketamine) based on grant of Fast Track designation for NRX-100 in the treatment of suicidal ideation in patients with depression, includi...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US29089Q1058
Emergent BioSolutions Inc
EBS
LISTED
NYSE
Emergent BioSolutions to Participate in Upcoming Investor Conferences
News Preview
GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US81734D1046
Septerna, Inc.
SEPN
LISTED
NASDAQ
Septerna to Participate in Upcoming Investor Conferences
News Preview
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced that management will participate in the following upcoming investor conferences in September:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US04300J1079
Protara Therapeutics, Inc.
TARA
LISTED
NASDAQ
Protara Therapeutics to Participate in Upcoming Investor Conferences
News Preview
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US63909J1088
Nautilus Biotechnology Inc
NAUT
LISTED
NASDAQ
Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
News Preview
SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US75382E1091
RAPT Therapeutics, Inc.
RAPT
LISTED
NASDAQ
RAPT Therapeutics to Participate in Multiple Upcoming Investor Conferences
News Preview
SOUTH SAN FRANCISCO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with inflammatory and immunological diseases, today announced that members of the RAPT managem...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US75062E1064
Rafael Holdings Inc
RFL
LISTED
NYSE
Rafael Holdings Announces Abstracts Accepted for Oral and Poster Presentations at the 15th International Congress of Inborn Errors of Metabolism (ICIEM)
News Preview
NEWARK, N.J., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rafael Holdings, Inc. (NYSE: RFL; NYSE American: RFL-WT) announced today that its subsidiary Cyclo Therapeutics has had two abstracts selected for presentation from its programs evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 at the upcoming 15th International Congress...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US25056L1035
Design Therapeutics Inc
DSGN
LISTED
NASDAQ
Design Therapeutics to Participate in the 2025 Cantor Global Healthcare Conference
News Preview
CARLSBAD, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a fireside chat at the 2025 Cantor Global Healthcare Conference on Thursday, September 4, 2025, at...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Soleno Therapeutics to Participate in Upcoming September Conferences
News Preview
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in September:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US6024961012
MiMedx Group Inc
MDXG
LISTED
NASDAQ
MIMEDX to Participate in Upcoming Investor Conferences
News Preview
MARIETTA, Ga., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US00461U1051
Aclaris Therapeutics Inc
ACRS
LISTED
NASDAQ
Aclaris Therapeutics to Participate in Two September Healthcare Conferences
News Preview
Aclaris Therapeutics to Participate in Two September Healthcare Conferences...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US09075P1057
BioXcel Therapeutics, Inc.
BTAI
LISTED
NASDAQ
UPDATE -- BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI®
News Preview
BXCL501 achieved SERENITY At-Home’s primary endpoint of being well tolerated in the at-home treatment of agitation episodes in patients with bipolar disorders or schizophrenia...
Themefolio
Profiler
Peergroup
© BusinessWire
27.08.2025
ISIN: US07725L1026
BeOne Medicines Ltd.
ONC
LISTED
NASDAQ
European Commission Approves TEVIMBRA® as Neoadjuvant/Adjuvant NSCLC Treatment Ahead of Late-Breaking Data Presentation at WCLC 2025
News Preview
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission (EC) has approved TEVIMBRA (tislelizumab), in combination with platinum-containing chemotherapy as neoadjuvant treatment followed by TEVIMBRA monotherapy as adjuvant treatment, for adult patients with resectable non...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US76200L3096
Rezolute, Inc.
RZLT
LISTED
NASDAQ
Rezolute to Participate in Upcoming Investor Conferences
News Preview
REDWOOD CITY, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that management will participate in the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US10806X1028
BridgeBio Pharma, Inc.
BBIO
LISTED
NASDAQ
BridgeBio to Participate in September Investor Conferences
News Preview
PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will host fireside chats at the following healthcare investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US26818M1080
Dyne Therapeutics Inc
DYN
LISTED
NASDAQ
Dyne Therapeutics to Present at Upcoming Investor Conferences
News Preview
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced that management is scheduled to present at the following upcoming investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US21077P1084
Context Therapeutics Inc.
CNTX
LISTED
NASDAQ
Context Therapeutics to Participate in Upcoming Investor Conferences
News Preview
PHILADELPHIA, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that the Company will participate in the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US92332V1070
Ventyx Biosciences Inc
VTYX
LISTED
NASDAQ
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
News Preview
SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases, today announced that Company executives will participate in the following...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US00534A1025
Invivyd Inc
IVVD
LISTED
NASDAQ
Invivyd to Participate in Upcoming Investor Conferences
News Preview
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that it will present at the following investor conferences:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US67576A1007
Ocular Therapeutix Inc
OCUL
LISTED
NASDAQ
Ocular Therapeutix™ to Participate in September Investor and Scientific Conferences
News Preview
BEDFORD, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today announced participation in several upcoming investor and scientific conferences in September 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US09075P1057
BioXcel Therapeutics, Inc.
BTAI
LISTED
NASDAQ
BioXcel Therapeutics Announces SERENITY At-Home Pivotal Phase 3 Safety Trial Met its Primary Endpoint in Support of sNDA Submission for Label Expansion of IGALMI®
News Preview
BXCL501 achieved SERENITY At-Home’s primary endpoint of being well tolerated in the at-home treatment of agitation episodes in patients with bipolar disorders or schizophrenia...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US83086J2006
Skye Bioscience Inc
SKYE
LISTED
NASDAQ
Skye Bioscience to Host Virtual KOL Event and Provide Perspectives on Upcoming CBeyond™ Phase 2a Topline Clinical Data Readout
News Preview
Virtual KOL event will begin at 8:00 AM ET on Thursday, September 4, 2025 Virtual KOL event will begin at 8:00 AM ET on Thursday, September 4, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US5015751044
Kymera Therapeutics Inc
KYMR
LISTED
NASDAQ
Kymera Therapeutics to Participate in Upcoming September Investor Conferences
News Preview
WATERTOWN, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events: ...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US81750R1023
Seres Therapeutics, Inc.
MCRB
LISTED
NASDAQ
Seres Therapeutics to Participate in H.C. Wainwright 27th Annual Global Investment Conference
News Preview
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will attend the upcoming H.C. Wainwright Global Investment Conference in New York City and will present a company overview at 3:00 p.m. ET on September 8, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US3441741077
Foghorn Therapeutics Inc
FHTX
LISTED
NASDAQ
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
News Preview
CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- August 27, 2025 -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression, today announced that management will participate in Citi’s 2025 Biopharma Back to School Su...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US8294011080
Sionna Therapeutics Inc
SION
LISTED
NASDAQ
Sionna Therapeutics to Participate in Upcoming September Investor Conferences
News Preview
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) pro...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US05464T1043
Axsome Therapeutics Inc
AXSM
LISTED
NASDAQ
Axsome Therapeutics to Participate in Upcoming Investor Conferences
News Preview
NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in the following upcoming investor conferences in September:...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: US03753U1060
Apellis Pharmaceuticals Inc
APLS
LISTED
NASDAQ
Apellis Pharmaceuticals to Participate in Upcoming Investor Conferences
News Preview
WALTHAM, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that management will participate in webcast fireside chats at the following investor conferences:...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.08.2025
ISIN: DE000STRA555
Stratec Se
SBS
LISTED
XETR
STRATEC MIT ERWEITERUNG DES VORSTANDS
News Preview
STRATEC MIT ERWEITERUNG DES VORSTANDS
Birkenfeld, 27. August 2025
Die STRATEC SE, Birkenfeld, Deutschland (Frankfurt: SBS; Prime Standard, SDAX), gibt bekannt, dass Frau Tanja Bücherl zum 1. November 2025 als Chief Financial Officer (CFO) in den Vorstand von STRATEC berufen wird. Sie wird damit den Verantwortungsbereich von Herrn Oliver Albrecht......
Themefolio
Profiler
Peergroup
© EQS Newswire
27.08.2025
ISIN: DE000STRA555
Stratec Se
SBS
LISTED
XETR
STRATEC ENLARGES ITS BOARD OF MANAGEMENT
News Preview
STRATEC ENLARGES ITS BOARD OF MANAGEMENT
Birkenfeld, August 27, 2025
STRATEC SE, Birkenfeld, Germany (Frankfurt: SBS; Prime Standard, SDAX), hereby announces that Tanja Bücherl will be appointed to its Board of Management as Chief Financial Officer (CFO) as of November 1, 2025. She will then take charge of the areas for which Oliver Albrecht, wh......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.08.2025
ISIN: US29350E1047
Enochian Biosciences, Inc
ENOB
LISTED
NASDAQ
Renovaro Inc. Announces Corporate Name Change to Lunai Bioworks, Inc., Reflecting Strategic Focus on AI-Driven Biodefense, Drug Discovery and Advanced Diagnostics
News Preview
LOS ANGELES, CALIFORNIA / ACCESS Newswire / August 27, 2025 / Renovaro Inc. (NASDAQ:RENB) today announced that it will change its corporate name to Lunai Bioworks, Inc. to better reflect its strategic direction and growing expertise in AI-powered biodefense, drug discovery and advanced diagnostics. The new name underscores the Company's commitment...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.08.2025
ISIN: US5845073056
Medical Care Technologies Inc.
MDCE
LISTED
OTC
NBA Game Used Auction: (OTC PINK:MDCE) Highlights Infinite Auctions & Real Game Used as "The Grail Collection" Nears Closing
News Preview
MESA, ARIZONA / ACCESS Newswire / August 27, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) is highlighting the strength of its subsidiaries Infinite Auctions (www.infiniteauctions.com) and Real Game Used (www.realgameused.com) as Infinite Auctions' "The Grail Collection" online auction features some of the most coveted game-used m...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.08.2025
ISIN: US45408X3089
IGC Pharma, Inc
IGC
LISTED
XASE
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q1 results. We believe more positive clinical data and progress in 2025 to be strong catalysts for stock. Raising P/T to $4.50."
News Preview
POTOMAC, MD / ACCESS Newswire / August 27, 2025 / IGC Pharma, Inc. (NYSE American:IGC) today announced that Ascendiant Capital Markets has issued a coverage report entitled: "Reports Q1 results. We believe more positive clinical data and progress in 2025 to be strong catalysts for stock. Raising P/T to $4.50." All reports on IGC Pharma pr...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: KYG5252B1023
Keymed Biosciences Inc.
2162
LISTED
HKSE
Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum
News Preview
CHENGDU, China, Aug. 27, 2025 /PRNewswire/ -- Keymed Biosciences Inc. ("Keymed", 02162.HK) announced impressive interim results for 2025, marked by accelerated commercialization and R&D progress.
Financially, the company achieved record revenue, driven by the strong performance of its core product, Stapokibart, an IL-4Rα antibody marketed as...
Themefolio
Profiler
Peergroup
© PR Newswire
27.08.2025
ISIN: KYG5252B1023
Keymed Biosciences Inc.
2162
LISTED
HKSE
Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum
News Preview
CHENGDU, China, Aug. 27, 2025 /PRNewswire/ -- Keymed Biosciences Inc. ("Keymed", 02162.HK) announced impressive interim results for 2025, marked by accelerated commercialization and R&D progress.
Financially, the company achieved record revenue, driven by the strong performance of its core product, Stapokibart, an IL-4Rα antibody marketed as...
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.08.2025
ISIN: US9495031067
Wellgistics Health, Inc.
WGRX
LISTED
NASDAQ
Wellgistics Health Introduces HubRx AI: Advancing the AI-Powered Prescription Ecosystem
News Preview
TAMPA, FL / ACCESS Newswire / August 27, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the introduction of HubRx AI - a fully customizable AI engine built...
Themefolio
Profiler
Peergroup
© Newsfile
27.08.2025
ISIN: NL0011832936
Cosmo Pharmaceuticals NV
COPN
LISTED
SIX
Cosmo Receives Positive CHMP Opinion for Winlevi(R) for Treatment of Acne in Adults and Adolescents, Following Successful Re-Examination
News Preview
Dublin, Ireland--(Newsfile Corp. - August 27, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending European approval of...
Themefolio
Profiler
Peergroup
© EQS Newswire
27.08.2025
ISIN: CH0210362643
BioVersys AG
BIOV
LISTED
XWSX
BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis
News Preview
Ad hoc announcement pursuant to Art. 53 LR
Basel, Switzerland, August 27, 2025, 7am CET
Orphan designation is granted to drug candidates addressing life-threatening or chronically debilitating diseases affecting fewer than 5 in 10’000 EU residents
EMA orphan status provides key incentives, including reduced fees, research and c......
Themefolio
Profiler
Peergroup
© ACCESSWIRE
27.08.2025
ISIN: US12482V1035
CBD Life Sciences Inc.
CBDL
LISTED
OTC
CBD Life Sciences Inc. (CBDL) Announces Company Will Exhibit at the NECANN Cannabis Conference in Atlantic City, NJ
News Preview
NECANN New Jersey attracts over 5,000 industry leaders, features more than 200 exhibitors, and is ranked the 3rd largest B2B cannabis convention in the United States - positioning CBDL for unprecedented growth, revenue opportunities, and investor value. SCOTTSDALE, ARIZONA / ACCESS Newswire / August 27, 2025 / CBD Life Sciences Inc. (OTC:CBDL), a t...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: BE0003755692
AGFA Gevaert NV
AGFB
LISTED
EURONEXT
The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, stable Digital Print & Chemicals performance – further decline in medical film
News Preview
Regulated information August 27, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q2 2025: strong HealthCare IT performance, stable Digital Print & Chemicals performance – further decline in medical film...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2025
ISIN: CH0363463438
Idorsia Ltd
IDIA
LISTED
SIX
Idorsia successfully completes convertible bonds restructuring
News Preview
Ad hoc announcement pursuant to Art. 53 LR...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
